title: [Bone marrow aplasia related to ticlopidine].
abstract: The authors report two cases of bone marrow aplasia observed 2 months after initiation of a treatment with ticlopidine. The outcome was favorable after discontinuation of therapy. The frequency of this severe drug-induced complication seems to have been underestimated. The absolute necessity of a careful haematological survey during the first 3 months of therapy is pointed out.
authors.affiliation: Service de médecine interne-oncologie, hôpital d'instruction des Armées Sainte-Anne, Toulon, France.
authors.forename: J P
authors.initials: JP
authors.lastname: de Jaureguiberry
authors.forename: M
authors.initials: M
authors.lastname: Galzin
authors.forename: P
authors.initials: P
authors.lastname: Talard
authors.forename: S
authors.initials: S
authors.lastname: Marlier
authors.forename: S
authors.initials: S
authors.lastname: Durupt
authors.forename: C
authors.initials: C
authors.lastname: Bouchiat
authors.forename: G V
authors.initials: GV
authors.lastname: Dussarat
authors.forename: D
authors.initials: D
authors.lastname: Jaubert
mesh_terms: D000368:Aged; D001855:Bone Marrow Diseases / Q000139:chemically induced* / Q000503:physiopathology; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine